Skip to content

Opening book details…

About this Medicine article

Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA by Johansen, Pierre; Hunt, Barnaby; Iyer, Neeraj N.; Dang-Tan, Tam; Pollock, Richard F. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Johansen, Pierre; Hunt, Barnaby; Iyer, Neeraj N.; Dang-Tan, Tam; Pollock, Richard F.
Publisher
Springer Healthcare Communications; Springer-Verlag; Springer International Publishing AG; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 0741-238X)
Published
2019
Field
Medicine (Health Sciences)

More by Johansen, Pierre; Hunt, Barnaby; Iyer, Neeraj N.; Dang-Tan, Tam; Pollock, Richard F.

Browse all works by Johansen, Pierre; Hunt, Barnaby; Iyer, Neeraj N.; Dang-Tan, Tam; Pollock, Richard F.